Eckert & Ziegler BEBIG SA (EZBG.BR) Quote| Reuters.com
Edition:
United States

Eckert & Ziegler BEBIG SA (EZBG.BR)

EZBG.BR on Brussels Stock Exchange

0.76EUR
11:35am EDT
Change (% chg)

€-0.12 (-13.64%)
Prev Close
€0.88
Open
€0.88
Day's High
€0.88
Day's Low
€0.75
Volume
91,336
Avg. Vol
1,852
52-wk High
€1.24
52-wk Low
€0.71

EZBG.BR

Chart for EZBG.BR

About

Eckert & Ziegler BEBIG SA is a Belgium-based company involved in the active implantable medical devices segment of the health care sector. The Company designs, develops and distributes interstitial implants used in brachytherapy for the treatment of cancer. The Company produces and markets three lines of products: Permanent... (more)
No analyst recommendations are available for EZBG.BR.

Overall

Beta: 0.46
Market Cap(Mil.): €15.45
Shares Outstanding(Mil.): 17.55
Dividend: --
Yield (%): --

Financials

  EZBG.BR Industry Sector
P/E (TTM): -- 55.13 34.67
EPS (TTM): -0.23 -- --
ROI: -8.25 5.46 14.11
ROE: -9.89 8.64 15.33

BRIEF-Eckert & Ziegler Q1 sales up 6 pct at EUR 35.8 mln

May 10 Eckert & Ziegler Strahlen- und Medizintechnik AG :

May 10 2016

BRIEF-Eckert & Ziegler BEBIG FY net loss widens to 4.1 mln euros

* Sales for 2015 were 31.1 million euros ($34.8 million), compared to 28.8 million euros in 2014

Mar 23 2016

BRIEF-Eckert & Ziegler FY net profit at 10.7 mln euros

* Said on Monday FY net profit for the year was 10.7 million euros ($12.04 million), or 2.03 euros per share

Mar 22 2016

BRIEF-Eckert & Ziegler expands cooperation program with drug developers

Feb 3 Eckert & Ziegler Strahlen und Medizintechnik AG :

Feb 03 2016

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.